3 chapters across the catalog
NPR reports on a Stanford Medicine discovery involving "megakaryocytes" in bone marrow that may explain why some vaccines offer longer immunity than others. The hosts remain skeptical, questioning why this information is only surfacing now and disputing the claim that the measles vaccine provides lifetime protection.
The hosts critique several "medical news" segments from ABC and NBC as thinly veiled native advertisements for Novo Nordisk and Pfizer. They point out that a pill version of semaglutide, Rybelsus, is already on the market for diabetes, but the current media blitz is focused on rebranding it specifically for weight loss. A Stanford doctor's claim that the drug is "safe and effective" is met with skepticism given the known side effects.
A listener's email challenges several claims made in previous episodes, specifically regarding the reversibility and physical side effects of vasectomies. While the listener cites medical studies showing no hormonal changes, the hosts maintain their anecdotal observations about changes in male mannerisms post-procedure.
